CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2007-06-15 | French Gregory M Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2007-06-15 | Schutz James J Vice President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2007-06-15 | Thornton Bruce Vice President | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2007-06-15 | Wokasch Michael Chief Operating Officer | Grant or award · Stock Option (right to buy) | +150,001 | 150,001 | ||
| 2007-04-26 | Miller Robert E Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −60,000 | 0 | ||
| 2007-04-26 | Miller Robert E Chief Financial Officer | Grant or award · Restricted Stock Units | +60,000 | $3.00 | $180K | 60,000 |
| 2007-04-20 | Birnbaum Jay E Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2007-01-30 | French Gregory M Director | Purchase | +10,000 | $7.81 | $78K | 28,750 |
| 2007-01-30 | Miller Robert E Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2007-01-30 | Conley Richard K Director | Conversion | +10,000 | 40,000 | ||
| 2007-01-30 | Conley Richard K Director | Conversion · Series A Preferred Stock | −10,000 | 0 | ||
| 2007-01-30 | Burlingame Robert Director | Conversion | +66,666 | 66,666 | ||
| 2007-01-30 | Burlingame Robert Director | Conversion · Series A Preferred Stock | −66,666 | 0 | ||
| 2007-01-24 | Burlingame Robert Director | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2007-01-24 | Burlingame Robert Director | Returned to the company · Stock Option (right to buy) | −75,000 | 0 | ||
| 2007-01-24 | Burlingame Robert Director | Grant or award · Warrant (right to buy) | +75,000 | 75,000 | ||
| 2007-01-24 | Burlingame Robert Director | Returned to the company · Warrant (right to buy) | −75,000 | 0 |
Page 19 of 19 · 377 trades